Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan
· Delayed Price · Currency is JPY 1,878.50
-42.00 (-2.19%)
At close: Mar 9, 2026
Sumitomo Pharma Revenue
Sumitomo Pharma had revenue of 120.62B JPY in the quarter ending December 31, 2025, with 7.28% growth. This brings the company's revenue in the last twelve months to 453.40B, up 21.65% year-over-year. In the fiscal year ending March 31, 2025, Sumitomo Pharma had annual revenue of 398.83B with 26.79% growth.
Revenue (ttm)
453.40B
Revenue Growth
+21.65%
P/S Ratio
1.65
Revenue / Employee
118.32M
Employees
3,832
Market Cap
746.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 398.83B | 84.27B | 26.79% |
| Mar 31, 2024 | 314.56B | -240.99B | -43.38% |
| Mar 31, 2023 | 555.54B | -4.49B | -0.80% |
| Mar 31, 2022 | 560.04B | 44.08B | 8.54% |
| Mar 31, 2021 | 515.95B | 33.22B | 6.88% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hisamitsu Pharmaceutical Co. | 159.27B |
| Eisai | 808.19B |
| Nippon Shinyaku | 166.05B |
| Toho Holdings | 1,539.60B |
| Tsumura & Co. | 189.50B |
| Sawai Group Holdings | 200.68B |
| Towa Pharmaceutical | 269.92B |
| Shionogi & | 465.38B |
Sumitomo Pharma News
- 17 days ago - Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment - CNBC